News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-22 5:1:18 am Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024 GlobeNewsWire
2024-03-18 11:18:0 am Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders GlobeNewswire
2024-03-18 11:18:0 am Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023 GlobeNewswire
2024-03-11 5:0:0 am Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base GlobeNewswire
2024-03-08 5:0:0 am Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients GlobeNewswire
2024-02-26 5:0:0 am Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference GlobeNewswire
2024-02-12 5:0:0 am Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions GlobeNewswire
2024-02-07 5:0:0 am Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts GlobeNewswire
2024-01-29 5:0:0 am Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information